transcatheter aortic valve replacement (TAVR)
transcatheter aortic valve replacement (TAVR) is a medical procedure with 7 clinical trials. Currently 3 active trials ongoing. Historical success rate of 66.7%.
Success Metrics
Based on 2 completed trials
Phase Distribution
Phase Distribution
0
Early Stage
0
Mid Stage
0
Late Stage
Highest Phase Reached
UnknownTrial Status & Enrollment
66.7%
2 of 3 finished
33.3%
1 ended early
3
trials recruiting
7
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Cardiac Amyloidosis in Patients With Aortic Stenosis
Trial of the F2 Filter and Delivery System for Embolic Protection During TAVR
Sapien 3 Transcatheter Aortic Valve Replacement in Young Aortic Valve Stenosis Patients From China
Evaluation of ARi With OpSens SavvyWire
Bicuspid Aortic Valve Replacement: Evaluation of Transcatheter Versus Surgery-Pilot Trial
Clinical Trials (7)
Cardiac Amyloidosis in Patients With Aortic Stenosis
Trial of the F2 Filter and Delivery System for Embolic Protection During TAVR
Sapien 3 Transcatheter Aortic Valve Replacement in Young Aortic Valve Stenosis Patients From China
Evaluation of ARi With OpSens SavvyWire
Bicuspid Aortic Valve Replacement: Evaluation of Transcatheter Versus Surgery-Pilot Trial
CENTERA PMCF: Post-Market Follow-up of the CENTERA Transcatheter Heart Valve System
European Study Evaluating the EMBLOK Embolic Protection System During TAVR
All 7 trials loaded
Drug Details
- Intervention Type
- PROCEDURE
- Total Trials
- 7